nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT3A—embryo—ovarian cancer	0.016	0.0672	CbGeAlD
Azacitidine—DNMT3A—decidua—ovarian cancer	0.0123	0.0518	CbGeAlD
Azacitidine—CDA—uterine cervix—ovarian cancer	0.0122	0.0514	CbGeAlD
Azacitidine—DNMT3A—RMTs methylate histone arginines—WDR77—ovarian cancer	0.0122	0.0711	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—NME2—ovarian cancer	0.0121	0.0711	CbGpPWpGaD
Azacitidine—CDA—decidua—ovarian cancer	0.0116	0.049	CbGeAlD
Azacitidine—CDA—endometrium—ovarian cancer	0.011	0.0465	CbGeAlD
Azacitidine—DNMT3A—gonad—ovarian cancer	0.0108	0.0456	CbGeAlD
Azacitidine—DNMT1—myometrium—ovarian cancer	0.01	0.0423	CbGeAlD
Azacitidine—DNMT3A—female reproductive system—ovarian cancer	0.00967	0.0408	CbGeAlD
Azacitidine—DNMT1—embryo—ovarian cancer	0.00965	0.0407	CbGeAlD
Azacitidine—DNMT1—Vinblastine—Vinorelbine—ovarian cancer	0.0089	1	CbGdCrCtD
Azacitidine—DNMT3A—female gonad—ovarian cancer	0.0088	0.0371	CbGeAlD
Azacitidine—DNMT3A—vagina—ovarian cancer	0.00875	0.0369	CbGeAlD
Azacitidine—CDA—bone marrow—ovarian cancer	0.00863	0.0364	CbGeAlD
Azacitidine—CDA—vagina—ovarian cancer	0.00827	0.0348	CbGeAlD
Azacitidine—DNMT1—epithelium—ovarian cancer	0.00787	0.0332	CbGeAlD
Azacitidine—DNMT3A—RMTs methylate histone arginines—ARID1A—ovarian cancer	0.00783	0.0458	CbGpPWpGaD
Azacitidine—DNMT1—uterine cervix—ovarian cancer	0.00781	0.0329	CbGeAlD
Azacitidine—DNMT3A—testis—ovarian cancer	0.00781	0.0329	CbGeAlD
Azacitidine—DNMT1—decidua—ovarian cancer	0.00744	0.0313	CbGeAlD
Azacitidine—CDA—testis—ovarian cancer	0.00738	0.0311	CbGeAlD
Azacitidine—CDA—Pyrimidine metabolism—TYMS—ovarian cancer	0.00707	0.0414	CbGpPWpGaD
Azacitidine—DNMT1—endometrium—ovarian cancer	0.00706	0.0298	CbGeAlD
Azacitidine—DNMT1—gonad—ovarian cancer	0.00655	0.0276	CbGeAlD
Azacitidine—DNMT3A—One Carbon Metabolism—TYMS—ovarian cancer	0.00652	0.0382	CbGpPWpGaD
Azacitidine—DNMT1—uterus—ovarian cancer	0.00651	0.0274	CbGeAlD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—TTF1—ovarian cancer	0.00646	0.0378	CbGpPWpGaD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—TYMS—ovarian cancer	0.00586	0.0343	CbGpPWpGaD
Azacitidine—DNMT1—female reproductive system—ovarian cancer	0.00585	0.0247	CbGeAlD
Azacitidine—DNMT3A—lymph node—ovarian cancer	0.00566	0.0238	CbGeAlD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.00552	0.0323	CbGpPWpGaD
Azacitidine—DNMT1—bone marrow—ovarian cancer	0.00552	0.0233	CbGeAlD
Azacitidine—CDA—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.00548	0.0321	CbGpPWpGaD
Azacitidine—CDA—lymph node—ovarian cancer	0.00535	0.0225	CbGeAlD
Azacitidine—DNMT1—female gonad—ovarian cancer	0.00532	0.0224	CbGeAlD
Azacitidine—DNMT1—vagina—ovarian cancer	0.00529	0.0223	CbGeAlD
Azacitidine—DNMT3A—Chromatin modifying enzymes—WDR77—ovarian cancer	0.00519	0.0304	CbGpPWpGaD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—TTF1—ovarian cancer	0.00504	0.0295	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—TTF1—ovarian cancer	0.00492	0.0288	CbGpPWpGaD
Azacitidine—Cladribine—NR5A1—ovarian cancer	0.0048	0.391	CrCbGaD
Azacitidine—DNMT1—testis—ovarian cancer	0.00472	0.0199	CbGeAlD
Azacitidine—DNMT3A—RMTs methylate histone arginines—SMARCA4—ovarian cancer	0.00471	0.0276	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—GADD45A—ovarian cancer	0.00463	0.0271	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—TYMS—ovarian cancer	0.00441	0.0258	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—TTF1—ovarian cancer	0.00436	0.0256	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—BRCA1—ovarian cancer	0.00396	0.0232	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—TYMS—ovarian cancer	0.00396	0.0232	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—SMARCA4—ovarian cancer	0.00353	0.0207	CbGpPWpGaD
Azacitidine—DNMT1—lymph node—ovarian cancer	0.00342	0.0144	CbGeAlD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—SKP2—ovarian cancer	0.00337	0.0197	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID1A—ovarian cancer	0.00335	0.0196	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—TYMS—ovarian cancer	0.00276	0.0161	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.0027	0.0158	CbGpPWpGaD
Azacitidine—Glucosamine—MMP9—ovarian cancer	0.00267	0.218	CrCbGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND2—ovarian cancer	0.00258	0.0151	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCNE1—ovarian cancer	0.00226	0.0132	CbGpPWpGaD
Azacitidine—Gemcitabine—TYMS—ovarian cancer	0.00222	0.181	CrCbGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—SMARCA4—ovarian cancer	0.00202	0.0118	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—ERBB2—ovarian cancer	0.00194	0.0114	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—ovarian cancer	0.00182	0.0106	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.00181	0.0106	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1B—ovarian cancer	0.0018	0.0105	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.00178	0.0104	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—MET—ovarian cancer	0.00173	0.0101	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—AKT1—ovarian cancer	0.00172	0.14	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—ovarian cancer	0.00172	0.01	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CCND1—ovarian cancer	0.00149	0.00874	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—ovarian cancer	0.00138	0.00806	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—WDR77—ovarian cancer	0.00138	0.00806	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN1B—ovarian cancer	0.00117	0.00686	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND1—ovarian cancer	0.00112	0.00654	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NME2—ovarian cancer	0.0011	0.00646	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—TTF1—ovarian cancer	0.00108	0.00632	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NR5A1—ovarian cancer	0.00098	0.00574	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000939	0.0055	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—WDR77—ovarian cancer	0.000929	0.00544	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000896	0.00524	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—TTF1—ovarian cancer	0.000729	0.00427	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000718	0.00421	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYTB—ovarian cancer	0.000711	0.00416	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NR5A1—ovarian cancer	0.000662	0.00388	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CCND1—ovarian cancer	0.000638	0.00374	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PPP1CC—ovarian cancer	0.000621	0.00364	CbGpPWpGaD
Azacitidine—CDA—Metabolism—BRIP1—ovarian cancer	0.000621	0.00364	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.00059	0.00345	CbGpPWpGaD
Azacitidine—Gemcitabine—ABCB1—ovarian cancer	0.000563	0.0458	CrCbGaD
Azacitidine—DNMT3A—Gene Expression—YAP1—ovarian cancer	0.000559	0.00327	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PGR—ovarian cancer	0.000488	0.00286	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PARP1—ovarian cancer	0.000454	0.00266	CbGpPWpGaD
Azacitidine—CDA—Metabolism—YAP1—ovarian cancer	0.000417	0.00244	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—YAP1—ovarian cancer	0.000378	0.00221	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PPP2R1A—ovarian cancer	0.000368	0.00216	CbGpPWpGaD
Azacitidine—CDA—Metabolism—FASN—ovarian cancer	0.00034	0.00199	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC5A5—ovarian cancer	0.000334	0.00196	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PGR—ovarian cancer	0.00033	0.00193	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC2A1—ovarian cancer	0.000323	0.00189	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP1B1—ovarian cancer	0.000309	0.00181	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PARP1—ovarian cancer	0.000307	0.00179	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ABCB1—ovarian cancer	0.0003	0.0245	CrCbGaD
Azacitidine—Neutropenia—Epirubicin—ovarian cancer	0.000283	0.000496	CcSEcCtD
Azacitidine—Rash—Vinorelbine—ovarian cancer	0.000282	0.000495	CcSEcCtD
Azacitidine—Dermatitis—Vinorelbine—ovarian cancer	0.000282	0.000494	CcSEcCtD
Azacitidine—Abdominal distension—Doxorubicin—ovarian cancer	0.000282	0.000494	CcSEcCtD
Azacitidine—Hypotension—Paclitaxel—ovarian cancer	0.000282	0.000493	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000282	0.000493	CcSEcCtD
Azacitidine—Headache—Vinorelbine—ovarian cancer	0.000281	0.000492	CcSEcCtD
Azacitidine—Syncope—Docetaxel—ovarian cancer	0.000281	0.000492	CcSEcCtD
Azacitidine—Dysphagia—Doxorubicin—ovarian cancer	0.00028	0.000491	CcSEcCtD
Azacitidine—Leukopenia—Docetaxel—ovarian cancer	0.00028	0.000491	CcSEcCtD
Azacitidine—Loss of consciousness—Docetaxel—ovarian cancer	0.000275	0.000482	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000274	0.000481	CcSEcCtD
Azacitidine—CDA—Metabolism—PPP2R1A—ovarian cancer	0.000274	0.00161	CbGpPWpGaD
Azacitidine—Weight decreased—Epirubicin—ovarian cancer	0.000274	0.00048	CcSEcCtD
Azacitidine—Cough—Docetaxel—ovarian cancer	0.000273	0.000478	CcSEcCtD
Azacitidine—Insomnia—Paclitaxel—ovarian cancer	0.000273	0.000477	CcSEcCtD
Azacitidine—Pneumonia—Epirubicin—ovarian cancer	0.000272	0.000476	CcSEcCtD
Azacitidine—Convulsion—Docetaxel—ovarian cancer	0.000271	0.000475	CcSEcCtD
Azacitidine—Hypertension—Docetaxel—ovarian cancer	0.00027	0.000473	CcSEcCtD
Azacitidine—Infestation NOS—Epirubicin—ovarian cancer	0.00027	0.000473	CcSEcCtD
Azacitidine—Infestation—Epirubicin—ovarian cancer	0.00027	0.000473	CcSEcCtD
Azacitidine—Bronchitis—Doxorubicin—ovarian cancer	0.00027	0.000472	CcSEcCtD
Azacitidine—Dyspnoea—Paclitaxel—ovarian cancer	0.000269	0.000471	CcSEcCtD
Azacitidine—Arthralgia—Docetaxel—ovarian cancer	0.000266	0.000467	CcSEcCtD
Azacitidine—Chest pain—Docetaxel—ovarian cancer	0.000266	0.000467	CcSEcCtD
Azacitidine—Myalgia—Docetaxel—ovarian cancer	0.000266	0.000467	CcSEcCtD
Azacitidine—Pancytopenia—Doxorubicin—ovarian cancer	0.000266	0.000466	CcSEcCtD
Azacitidine—Nausea—Vinorelbine—ovarian cancer	0.000266	0.000466	CcSEcCtD
Azacitidine—Renal failure—Epirubicin—ovarian cancer	0.000265	0.000465	CcSEcCtD
Azacitidine—Dyspepsia—Paclitaxel—ovarian cancer	0.000265	0.000465	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000265	0.000464	CcSEcCtD
Azacitidine—Stomatitis—Epirubicin—ovarian cancer	0.000263	0.000461	CcSEcCtD
Azacitidine—Urinary tract infection—Epirubicin—ovarian cancer	0.000263	0.00046	CcSEcCtD
Azacitidine—Neutropenia—Doxorubicin—ovarian cancer	0.000262	0.000459	CcSEcCtD
Azacitidine—Dysuria—Doxorubicin—ovarian cancer	0.000262	0.000459	CcSEcCtD
Azacitidine—Decreased appetite—Paclitaxel—ovarian cancer	0.000262	0.000459	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—ESR1—ovarian cancer	0.000261	0.00153	CbGpPWpGaD
Azacitidine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00026	0.000456	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00026	0.000456	CcSEcCtD
Azacitidine—Fatigue—Paclitaxel—ovarian cancer	0.00026	0.000455	CcSEcCtD
Azacitidine—Pain—Paclitaxel—ovarian cancer	0.000258	0.000451	CcSEcCtD
Azacitidine—Constipation—Paclitaxel—ovarian cancer	0.000258	0.000451	CcSEcCtD
Azacitidine—Haematuria—Epirubicin—ovarian cancer	0.000258	0.000451	CcSEcCtD
Azacitidine—Confusional state—Docetaxel—ovarian cancer	0.000257	0.000451	CcSEcCtD
Azacitidine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000255	0.000448	CcSEcCtD
Azacitidine—Oedema—Docetaxel—ovarian cancer	0.000255	0.000447	CcSEcCtD
Azacitidine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000255	0.000447	CcSEcCtD
Azacitidine—CDA—Metabolism—ABCB1—ovarian cancer	0.000255	0.00149	CbGpPWpGaD
Azacitidine—Epistaxis—Epirubicin—ovarian cancer	0.000255	0.000446	CcSEcCtD
Azacitidine—Infection—Docetaxel—ovarian cancer	0.000254	0.000445	CcSEcCtD
Azacitidine—Weight decreased—Doxorubicin—ovarian cancer	0.000254	0.000444	CcSEcCtD
Azacitidine—Sinusitis—Epirubicin—ovarian cancer	0.000253	0.000444	CcSEcCtD
Azacitidine—Agranulocytosis—Epirubicin—ovarian cancer	0.000252	0.000442	CcSEcCtD
Azacitidine—Pneumonia—Doxorubicin—ovarian cancer	0.000251	0.00044	CcSEcCtD
Azacitidine—Shock—Docetaxel—ovarian cancer	0.000251	0.00044	CcSEcCtD
Azacitidine—Nervous system disorder—Docetaxel—ovarian cancer	0.00025	0.000439	CcSEcCtD
Azacitidine—CDA—Metabolism—TYMS—ovarian cancer	0.00025	0.00147	CbGpPWpGaD
Azacitidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00025	0.000438	CcSEcCtD
Azacitidine—Infestation—Doxorubicin—ovarian cancer	0.00025	0.000438	CcSEcCtD
Azacitidine—Infestation NOS—Doxorubicin—ovarian cancer	0.00025	0.000438	CcSEcCtD
Azacitidine—Tachycardia—Docetaxel—ovarian cancer	0.000249	0.000437	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—PPP2R1A—ovarian cancer	0.000249	0.00146	CbGpPWpGaD
Azacitidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000248	0.000435	CcSEcCtD
Azacitidine—Skin disorder—Docetaxel—ovarian cancer	0.000248	0.000435	CcSEcCtD
Azacitidine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000246	0.000432	CcSEcCtD
Azacitidine—Renal failure—Doxorubicin—ovarian cancer	0.000246	0.00043	CcSEcCtD
Azacitidine—Haemoglobin—Epirubicin—ovarian cancer	0.000244	0.000427	CcSEcCtD
Azacitidine—Stomatitis—Doxorubicin—ovarian cancer	0.000244	0.000427	CcSEcCtD
Azacitidine—Anorexia—Docetaxel—ovarian cancer	0.000243	0.000427	CcSEcCtD
Azacitidine—Rhinitis—Epirubicin—ovarian cancer	0.000243	0.000426	CcSEcCtD
Azacitidine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000243	0.000426	CcSEcCtD
Azacitidine—Haemorrhage—Epirubicin—ovarian cancer	0.000242	0.000425	CcSEcCtD
Azacitidine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000241	0.000423	CcSEcCtD
Azacitidine—Pharyngitis—Epirubicin—ovarian cancer	0.000241	0.000422	CcSEcCtD
Azacitidine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000239	0.00042	CcSEcCtD
Azacitidine—Urticaria—Paclitaxel—ovarian cancer	0.000239	0.000419	CcSEcCtD
Azacitidine—Oedema peripheral—Epirubicin—ovarian cancer	0.000239	0.000418	CcSEcCtD
Azacitidine—Hypotension—Docetaxel—ovarian cancer	0.000239	0.000418	CcSEcCtD
Azacitidine—Haematuria—Doxorubicin—ovarian cancer	0.000238	0.000417	CcSEcCtD
Azacitidine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000238	0.000417	CcSEcCtD
Azacitidine—Abdominal pain—Paclitaxel—ovarian cancer	0.000238	0.000417	CcSEcCtD
Azacitidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000238	0.000417	CcSEcCtD
Azacitidine—Urethral disorder—Epirubicin—ovarian cancer	0.000238	0.000416	CcSEcCtD
Azacitidine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000236	0.000414	CcSEcCtD
Azacitidine—Epistaxis—Doxorubicin—ovarian cancer	0.000236	0.000413	CcSEcCtD
Azacitidine—Sinusitis—Doxorubicin—ovarian cancer	0.000234	0.000411	CcSEcCtD
Azacitidine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000233	0.000409	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000233	0.000408	CcSEcCtD
Azacitidine—Insomnia—Docetaxel—ovarian cancer	0.000231	0.000405	CcSEcCtD
Azacitidine—Dyspnoea—Docetaxel—ovarian cancer	0.000228	0.000399	CcSEcCtD
Azacitidine—Eye disorder—Epirubicin—ovarian cancer	0.000227	0.000397	CcSEcCtD
Azacitidine—Haemoglobin—Doxorubicin—ovarian cancer	0.000225	0.000395	CcSEcCtD
Azacitidine—Cardiac disorder—Epirubicin—ovarian cancer	0.000225	0.000394	CcSEcCtD
Azacitidine—Rhinitis—Doxorubicin—ovarian cancer	0.000225	0.000394	CcSEcCtD
Azacitidine—Dyspepsia—Docetaxel—ovarian cancer	0.000225	0.000394	CcSEcCtD
Azacitidine—Haemorrhage—Doxorubicin—ovarian cancer	0.000224	0.000393	CcSEcCtD
Azacitidine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000223	0.000391	CcSEcCtD
Azacitidine—Pharyngitis—Doxorubicin—ovarian cancer	0.000223	0.00039	CcSEcCtD
Azacitidine—Decreased appetite—Docetaxel—ovarian cancer	0.000222	0.000389	CcSEcCtD
Azacitidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000222	0.000389	CcSEcCtD
Azacitidine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000222	0.000388	CcSEcCtD
Azacitidine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000221	0.000387	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00022	0.000386	CcSEcCtD
Azacitidine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00022	0.000386	CcSEcCtD
Azacitidine—Fatigue—Docetaxel—ovarian cancer	0.00022	0.000386	CcSEcCtD
Azacitidine—Angiopathy—Epirubicin—ovarian cancer	0.00022	0.000385	CcSEcCtD
Azacitidine—Urethral disorder—Doxorubicin—ovarian cancer	0.00022	0.000385	CcSEcCtD
Azacitidine—Immune system disorder—Epirubicin—ovarian cancer	0.000219	0.000384	CcSEcCtD
Azacitidine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000219	0.000383	CcSEcCtD
Azacitidine—Constipation—Docetaxel—ovarian cancer	0.000218	0.000383	CcSEcCtD
Azacitidine—Pain—Docetaxel—ovarian cancer	0.000218	0.000383	CcSEcCtD
Azacitidine—Chills—Epirubicin—ovarian cancer	0.000218	0.000381	CcSEcCtD
Azacitidine—Asthenia—Paclitaxel—ovarian cancer	0.000216	0.000379	CcSEcCtD
Azacitidine—Alopecia—Epirubicin—ovarian cancer	0.000214	0.000375	CcSEcCtD
Azacitidine—Pruritus—Paclitaxel—ovarian cancer	0.000213	0.000373	CcSEcCtD
Azacitidine—Mental disorder—Epirubicin—ovarian cancer	0.000212	0.000372	CcSEcCtD
Azacitidine—Erythema—Epirubicin—ovarian cancer	0.000211	0.00037	CcSEcCtD
Azacitidine—Malnutrition—Epirubicin—ovarian cancer	0.000211	0.00037	CcSEcCtD
Azacitidine—Feeling abnormal—Docetaxel—ovarian cancer	0.00021	0.000369	CcSEcCtD
Azacitidine—Eye disorder—Doxorubicin—ovarian cancer	0.00021	0.000367	CcSEcCtD
Azacitidine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000209	0.000366	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000208	0.000365	CcSEcCtD
Azacitidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000206	0.000361	CcSEcCtD
Azacitidine—Back pain—Epirubicin—ovarian cancer	0.000204	0.000358	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—ovarian cancer	0.000204	0.000357	CcSEcCtD
Azacitidine—Muscle spasms—Epirubicin—ovarian cancer	0.000203	0.000356	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—ovarian cancer	0.000203	0.000355	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000202	0.000354	CcSEcCtD
Azacitidine—Body temperature increased—Docetaxel—ovarian cancer	0.000202	0.000354	CcSEcCtD
Azacitidine—Abdominal pain—Docetaxel—ovarian cancer	0.000202	0.000354	CcSEcCtD
Azacitidine—CDA—Metabolism—CAV1—ovarian cancer	0.000202	0.00118	CbGpPWpGaD
Azacitidine—Chills—Doxorubicin—ovarian cancer	0.000201	0.000353	CcSEcCtD
Azacitidine—Dizziness—Paclitaxel—ovarian cancer	0.000199	0.000349	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—ovarian cancer	0.000198	0.000347	CcSEcCtD
Azacitidine—Mental disorder—Doxorubicin—ovarian cancer	0.000197	0.000344	CcSEcCtD
Azacitidine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000196	0.000343	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—ovarian cancer	0.000195	0.000342	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—ovarian cancer	0.000195	0.000342	CcSEcCtD
Azacitidine—Anaemia—Epirubicin—ovarian cancer	0.000195	0.000342	CcSEcCtD
Azacitidine—Vomiting—Paclitaxel—ovarian cancer	0.000192	0.000336	CcSEcCtD
Azacitidine—Malaise—Epirubicin—ovarian cancer	0.00019	0.000333	CcSEcCtD
Azacitidine—Rash—Paclitaxel—ovarian cancer	0.00019	0.000333	CcSEcCtD
Azacitidine—Dermatitis—Paclitaxel—ovarian cancer	0.00019	0.000333	CcSEcCtD
Azacitidine—Syncope—Epirubicin—ovarian cancer	0.000189	0.000332	CcSEcCtD
Azacitidine—Leukopenia—Epirubicin—ovarian cancer	0.000189	0.000331	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—ovarian cancer	0.000189	0.000331	CcSEcCtD
Azacitidine—Headache—Paclitaxel—ovarian cancer	0.000189	0.000331	CcSEcCtD
Azacitidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000188	0.00033	CcSEcCtD
Azacitidine—Muscle spasms—Doxorubicin—ovarian cancer	0.000188	0.000329	CcSEcCtD
Azacitidine—Loss of consciousness—Epirubicin—ovarian cancer	0.000185	0.000325	CcSEcCtD
Azacitidine—Cough—Epirubicin—ovarian cancer	0.000184	0.000323	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CG—ovarian cancer	0.000184	0.00108	CbGpPWpGaD
Azacitidine—Asthenia—Docetaxel—ovarian cancer	0.000183	0.000321	CcSEcCtD
Azacitidine—Convulsion—Epirubicin—ovarian cancer	0.000183	0.00032	CcSEcCtD
Azacitidine—Hypertension—Epirubicin—ovarian cancer	0.000182	0.000319	CcSEcCtD
Azacitidine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000181	0.000317	CcSEcCtD
Azacitidine—Pruritus—Docetaxel—ovarian cancer	0.000181	0.000317	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—ovarian cancer	0.00018	0.000316	CcSEcCtD
Azacitidine—Chest pain—Epirubicin—ovarian cancer	0.00018	0.000315	CcSEcCtD
Azacitidine—Arthralgia—Epirubicin—ovarian cancer	0.00018	0.000315	CcSEcCtD
Azacitidine—Myalgia—Epirubicin—ovarian cancer	0.00018	0.000315	CcSEcCtD
Azacitidine—Anxiety—Epirubicin—ovarian cancer	0.000179	0.000314	CcSEcCtD
Azacitidine—Nausea—Paclitaxel—ovarian cancer	0.000179	0.000314	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000178	0.000313	CcSEcCtD
Azacitidine—Discomfort—Epirubicin—ovarian cancer	0.000178	0.000311	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—ovarian cancer	0.000176	0.000309	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—ESR1—ovarian cancer	0.000176	0.00103	CbGpPWpGaD
Azacitidine—Syncope—Doxorubicin—ovarian cancer	0.000175	0.000307	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—ovarian cancer	0.000175	0.000306	CcSEcCtD
Azacitidine—Diarrhoea—Docetaxel—ovarian cancer	0.000175	0.000306	CcSEcCtD
Azacitidine—Confusional state—Epirubicin—ovarian cancer	0.000174	0.000304	CcSEcCtD
Azacitidine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000172	0.000302	CcSEcCtD
Azacitidine—Oedema—Epirubicin—ovarian cancer	0.000172	0.000302	CcSEcCtD
Azacitidine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000172	0.000301	CcSEcCtD
Azacitidine—Infection—Epirubicin—ovarian cancer	0.000171	0.0003	CcSEcCtD
Azacitidine—Cough—Doxorubicin—ovarian cancer	0.00017	0.000299	CcSEcCtD
Azacitidine—Shock—Epirubicin—ovarian cancer	0.000169	0.000297	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—ovarian cancer	0.000169	0.000296	CcSEcCtD
Azacitidine—Nervous system disorder—Epirubicin—ovarian cancer	0.000169	0.000296	CcSEcCtD
Azacitidine—Dizziness—Docetaxel—ovarian cancer	0.000169	0.000296	CcSEcCtD
Azacitidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000169	0.000295	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—ovarian cancer	0.000169	0.000295	CcSEcCtD
Azacitidine—Tachycardia—Epirubicin—ovarian cancer	0.000168	0.000295	CcSEcCtD
Azacitidine—Skin disorder—Epirubicin—ovarian cancer	0.000167	0.000293	CcSEcCtD
Azacitidine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000167	0.000292	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—ovarian cancer	0.000166	0.000291	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—ovarian cancer	0.000166	0.000291	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—ovarian cancer	0.000166	0.000291	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—ovarian cancer	0.000166	0.00029	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000165	0.000289	CcSEcCtD
Azacitidine—Discomfort—Doxorubicin—ovarian cancer	0.000164	0.000288	CcSEcCtD
Azacitidine—Anorexia—Epirubicin—ovarian cancer	0.000164	0.000288	CcSEcCtD
Azacitidine—Vomiting—Docetaxel—ovarian cancer	0.000162	0.000284	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CD—ovarian cancer	0.000161	0.000945	CbGpPWpGaD
Azacitidine—Rash—Docetaxel—ovarian cancer	0.000161	0.000282	CcSEcCtD
Azacitidine—Hypotension—Epirubicin—ovarian cancer	0.000161	0.000282	CcSEcCtD
Azacitidine—Dermatitis—Docetaxel—ovarian cancer	0.000161	0.000282	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—ovarian cancer	0.000161	0.000282	CcSEcCtD
Azacitidine—Headache—Docetaxel—ovarian cancer	0.00016	0.00028	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—ovarian cancer	0.000159	0.000279	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000159	0.000279	CcSEcCtD
Azacitidine—Infection—Doxorubicin—ovarian cancer	0.000158	0.000277	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000157	0.000275	CcSEcCtD
Azacitidine—Shock—Doxorubicin—ovarian cancer	0.000157	0.000275	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000156	0.000274	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000156	0.000273	CcSEcCtD
Azacitidine—Insomnia—Epirubicin—ovarian cancer	0.000156	0.000273	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—ovarian cancer	0.000156	0.000273	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—ovarian cancer	0.000155	0.000271	CcSEcCtD
Azacitidine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000154	0.00027	CcSEcCtD
Azacitidine—Dyspnoea—Epirubicin—ovarian cancer	0.000154	0.000269	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—ovarian cancer	0.000152	0.000266	CcSEcCtD
Azacitidine—Nausea—Docetaxel—ovarian cancer	0.000152	0.000266	CcSEcCtD
Azacitidine—Dyspepsia—Epirubicin—ovarian cancer	0.000152	0.000266	CcSEcCtD
Azacitidine—Decreased appetite—Epirubicin—ovarian cancer	0.00015	0.000262	CcSEcCtD
Azacitidine—Hypotension—Doxorubicin—ovarian cancer	0.000149	0.000261	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000149	0.000261	CcSEcCtD
Azacitidine—Fatigue—Epirubicin—ovarian cancer	0.000149	0.00026	CcSEcCtD
Azacitidine—Constipation—Epirubicin—ovarian cancer	0.000147	0.000258	CcSEcCtD
Azacitidine—Pain—Epirubicin—ovarian cancer	0.000147	0.000258	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000145	0.000254	CcSEcCtD
Azacitidine—Insomnia—Doxorubicin—ovarian cancer	0.000144	0.000253	CcSEcCtD
Azacitidine—Dyspnoea—Doxorubicin—ovarian cancer	0.000142	0.000249	CcSEcCtD
Azacitidine—Feeling abnormal—Epirubicin—ovarian cancer	0.000142	0.000249	CcSEcCtD
Azacitidine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000141	0.000247	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CB—ovarian cancer	0.000141	0.000824	CbGpPWpGaD
Azacitidine—Dyspepsia—Doxorubicin—ovarian cancer	0.00014	0.000246	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—MAPK3—ovarian cancer	0.000139	0.000816	CbGpPWpGaD
Azacitidine—Decreased appetite—Doxorubicin—ovarian cancer	0.000139	0.000243	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000138	0.000241	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—ovarian cancer	0.000137	0.000241	CcSEcCtD
Azacitidine—Urticaria—Epirubicin—ovarian cancer	0.000137	0.00024	CcSEcCtD
Azacitidine—Pain—Doxorubicin—ovarian cancer	0.000136	0.000239	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—ovarian cancer	0.000136	0.000239	CcSEcCtD
Azacitidine—Abdominal pain—Epirubicin—ovarian cancer	0.000136	0.000239	CcSEcCtD
Azacitidine—Body temperature increased—Epirubicin—ovarian cancer	0.000136	0.000239	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—MYC—ovarian cancer	0.000136	0.000794	CbGpPWpGaD
Azacitidine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000131	0.00023	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00013	0.000228	CcSEcCtD
Azacitidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000127	0.000222	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—ovarian cancer	0.000127	0.000222	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—ovarian cancer	0.000126	0.000221	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—ovarian cancer	0.000126	0.000221	CcSEcCtD
Azacitidine—Asthenia—Epirubicin—ovarian cancer	0.000124	0.000217	CcSEcCtD
Azacitidine—Pruritus—Epirubicin—ovarian cancer	0.000122	0.000214	CcSEcCtD
Azacitidine—CDA—Metabolism—PTEN—ovarian cancer	0.000122	0.000712	CbGpPWpGaD
Azacitidine—Diarrhoea—Epirubicin—ovarian cancer	0.000118	0.000206	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000117	0.000206	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—ovarian cancer	0.000114	0.0002	CcSEcCtD
Azacitidine—Dizziness—Epirubicin—ovarian cancer	0.000114	0.0002	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—ovarian cancer	0.000113	0.000198	CcSEcCtD
Azacitidine—Vomiting—Epirubicin—ovarian cancer	0.00011	0.000192	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—ovarian cancer	0.000109	0.000191	CcSEcCtD
Azacitidine—Rash—Epirubicin—ovarian cancer	0.000109	0.00019	CcSEcCtD
Azacitidine—Dermatitis—Epirubicin—ovarian cancer	0.000109	0.00019	CcSEcCtD
Azacitidine—Headache—Epirubicin—ovarian cancer	0.000108	0.000189	CcSEcCtD
Azacitidine—Dizziness—Doxorubicin—ovarian cancer	0.000105	0.000185	CcSEcCtD
Azacitidine—Nausea—Epirubicin—ovarian cancer	0.000102	0.000179	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—ovarian cancer	0.000101	0.000178	CcSEcCtD
Azacitidine—Rash—Doxorubicin—ovarian cancer	0.0001	0.000176	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—ovarian cancer	0.0001	0.000176	CcSEcCtD
Azacitidine—Headache—Doxorubicin—ovarian cancer	9.98e-05	0.000175	CcSEcCtD
Azacitidine—Nausea—Doxorubicin—ovarian cancer	9.47e-05	0.000166	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—MAPK3—ovarian cancer	9.42e-05	0.000551	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—AKT1—ovarian cancer	9.4e-05	0.000551	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—MYC—ovarian cancer	9.16e-05	0.000536	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PIK3CA—ovarian cancer	8.58e-05	0.000502	CbGpPWpGaD
Azacitidine—CDA—Metabolism—AKT1—ovarian cancer	7.01e-05	0.00041	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—AKT1—ovarian cancer	6.35e-05	0.000372	CbGpPWpGaD
